Research ArticleClinical Studies
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
YASUSHI IDE, TAIGA OTSUKA, MOTOTSUGU SHIMOKAWA, FUTA KOGA, YUJIRO UEDA, JUNICHI NAKAZAWA, AZUSA KOMORI, SATOSHI OTSU, SHIHO ARIMA, MASARU FUKAHORI, AKITAKA MAKIYAMA, YUDAI SHINOHARA, SHOHEI UENO, HIROKI TAGUCHI, TAKUYA HONDA, TARO SHIBUKI, KENTA NIO, NORIO URESHINO, TOSHIHIKO MIZUTA, KENJI MITSUGI and TSUYOSHI SHIRAKAWA
Anticancer Research April 2023, 43 (4) 1817-1826; DOI: https://doi.org/10.21873/anticanres.16335
YASUSHI IDE
1Department of Internal Medicine, Karatsu Red Cross Hospital, Saga, Japan;
2Department of Internal Medicine, National Hospital Organization Saga Hospital, Saga, Japan;
TAIGA OTSUKA
3Department of Medical Oncology, Saga Medical Center Koseikan, Saga, Japan;
4Department of Internal Medicine, Minato Medical Clinic, Fukuoka, Japan;
MOTOTSUGU SHIMOKAWA
5Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan;
6Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan;
FUTA KOGA
7Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga, Japan;
YUJIRO UEDA
8Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan;
JUNICHI NAKAZAWA
9Department of Medical Oncology, Kagoshima City Hospital, Kagoshima, Japan;
AZUSA KOMORI
10Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan;
SATOSHI OTSU
10Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan;
SHIHO ARIMA
11Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan;
MASARU FUKAHORI
12Department of Internal Medicine, Division of Gastroenterology, Kurume University Hospital, Fukuoka, Japan;
AKITAKA MAKIYAMA
13Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan;
14Cancer Center, Gifu University Hospital, Gifu, Japan;
YUDAI SHINOHARA
13Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan;
SHOHEI UENO
13Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan;
HIROKI TAGUCHI
15Department of Gastroenterology, Saiseikai Sendai Hospital, Kagoshima, Japan;
16Department of Gastroenterology, Imamura General Hospital, Kagoshima, Japan;
TAKUYA HONDA
17Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
TARO SHIBUKI
18Department of Internal Medicine, Imari Arita Kyoritsu Hospital, Saga, Japan;
19Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan;
KENTA NIO
20Department of Medical Oncology, Sasebo Kyosai Hospital, Nagasaki, Japan;
21Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan;
NORIO URESHINO
3Department of Medical Oncology, Saga Medical Center Koseikan, Saga, Japan;
22Department of Medical Oncology, Kimitsu Chuo Hospital, Chiba, Japan;
TOSHIHIKO MIZUTA
23Department of Internal Medicine, Fujikawa Hospital, Saga, Japan;
KENJI MITSUGI
20Department of Medical Oncology, Sasebo Kyosai Hospital, Nagasaki, Japan;
21Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan;
TSUYOSHI SHIRAKAWA
24Department of Medical Oncology, Fukuoka Wajiro Hospital, Fukuoka, Japan;
25Department of Internal Medicine, Karatsu Higashi-matsuura Medical Association Center, Saga, Japan
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
YASUSHI IDE, TAIGA OTSUKA, MOTOTSUGU SHIMOKAWA, FUTA KOGA, YUJIRO UEDA, JUNICHI NAKAZAWA, AZUSA KOMORI, SATOSHI OTSU, SHIHO ARIMA, MASARU FUKAHORI, AKITAKA MAKIYAMA, YUDAI SHINOHARA, SHOHEI UENO, HIROKI TAGUCHI, TAKUYA HONDA, TARO SHIBUKI, KENTA NIO, NORIO URESHINO, TOSHIHIKO MIZUTA, KENJI MITSUGI, TSUYOSHI SHIRAKAWA
Anticancer Research Apr 2023, 43 (4) 1817-1826; DOI: 10.21873/anticanres.16335
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
YASUSHI IDE, TAIGA OTSUKA, MOTOTSUGU SHIMOKAWA, FUTA KOGA, YUJIRO UEDA, JUNICHI NAKAZAWA, AZUSA KOMORI, SATOSHI OTSU, SHIHO ARIMA, MASARU FUKAHORI, AKITAKA MAKIYAMA, YUDAI SHINOHARA, SHOHEI UENO, HIROKI TAGUCHI, TAKUYA HONDA, TARO SHIBUKI, KENTA NIO, NORIO URESHINO, TOSHIHIKO MIZUTA, KENJI MITSUGI, TSUYOSHI SHIRAKAWA
Anticancer Research Apr 2023, 43 (4) 1817-1826; DOI: 10.21873/anticanres.16335
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.